• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	119,000	12.07.24 09:04:13	+1,000	+0,85%	118,400	119,200	119,000	118,000
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	90,000	12.07.24 08:56:55	+1,500	+1,69%	89,500	90,500	90,000	88,500